A global view of regulations affecting nanomaterials.

The 2000s have been characterized by an unprecedented exploration into research and development of nanotechnology and nanomaterials. Despite a slow start, new regulatory initiatives are popping up like mushrooms internationally. Many of these initiatives have yet to materialize themselves or are soft law initiatives, and their impact on the development of more authoritative and prescriptive regulatory measures is most likely to be limited. This is due to a number of transnational regulatory challenges that include: (1) whether to adapt existing legislation or develop a new regulatory framework, (2) whether nanomaterials should be considered as different from their bulk counterparts, (3) how to define nanotechnology and nanomaterials, and (4) how to deal with the profound limitations of risk assessment when it comes to nanomaterials. In this opinion, I discuss these and related issues and conclude that the development of a new authoritative and prescriptive regulatory framework might be the only way to effectively address these challenges while ensuring a transparent and informed decision-making process.

[1]  E. Oberdörster.  Manufactured Nanomaterials (Fullerenes, C60) Induce Oxidative Stress in the Brain of Juvenile Largemouth Bass , 2004, Environmental health perspectives.

[2]  Steffen Foss Hansen,et al.  Late lessons from early warnings for nanotechnology. , 2008, Nature nanotechnology.

[3]  Zissis Samaras,et al.  Hazard and Risk Assessment of a Nanoparticulate Cerium Oxide-Based Diesel Fuel Additive—A Case Study , 2008, Inhalation toxicology.

[4]  J. James,et al.  Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[5]  John M. Balbus,et al.  Protecting workers and the environment: An environmental NGO’s perspective on nanotechnology , 2006 .

[6]  Steffen Foss Hansen,et al.  Categorization framework to aid exposure assessment of nanomaterials in consumer products , 2008, Ecotoxicology.

[7]  J. Tickner,et al.  Putting risk‐risk tradeoffs in perspective: a response to Graham and Wiener , 2008 .

[8]  David Rejeski,et al.  Too small to overlook , 2009, Nature.

[9]  Igor Linkov,et al.  Nano Risk Governance: Current Developments and Future Perspectives , 2009 .

[10]  Nanna B. Hartmann,et al.  Toxicity and bioaccumulation of xenobiotic organic compounds in the presence of aqueous suspensions of aggregates of nano-C(60). , 2008, Aquatic toxicology.

[11]  Craig A. Poland,et al.  Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. , 2008, Nature nanotechnology.

[12]  S. Olsen,et al.  Limits and prospects of the "incremental approach" and the European legislation on the management of risks related to nanomaterials. , 2007, Regulatory toxicology and pharmacology : RTP.